MedPath

The Expression Profile of New Complement Components in Childhood Lupus Nephritis

Conditions
Lupus Nephritis
Interventions
Combination Product: C4d evaluation in lupus nephritis in serum and renal tissue
Registration Number
NCT05082363
Lead Sponsor
Assiut University
Brief Summary

The aim of this study was to evaluate whether C4d is a better biomarker and examine whether C4d plasma levels correlate with treatment response and C4d kidney deposition in systemic lupus erythematosus (SLE) with lupus nephritis (LN).

Detailed Description

Evaluation of C4d in lupus nephritis in children C4d level difference in children with systemic lupus with and without renal affection C4d level in lupus nephritis at activity and after remission Detection of C4d deposition in renal tissue relation to disease activity

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • This will include children and adolescents who fulfill the 2012 Systemic Lupus International Collaborating Clinics (SLICC)(10) classification criteria of SLE.

    • Inclusion Criteria:

      • Age younger than 18 years.
      • Active SLE with and without renal affection
      • Patients with biopsy proven LN according to ISN/RPS classification criteria of Lupus nephritis.
Exclusion Criteria
  • -Patients in remission.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
systemic lupus wth renal affectionC4d evaluation in lupus nephritis in serum and renal tissuept diagnosed with lupus nephritis
systemic lupus without renal affectionC4d evaluation in lupus nephritis in serum and renal tissuept diagnosed as systemic lupus without renal affection
Primary Outcome Measures
NameTimeMethod
Evaluation of C4d in lupus nephritis in children2 years
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath